Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old
NCT02432911
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
300
Enrollment
UNKNOWN
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
CAG regimen (Aclacinomycin, cytarabine, with/w/o G-CSF)
DRUG:
low dose cytarabine
Sponsor
Jianxiang Wang